Related Experiment Video
Updated: May 9, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
A Novel Follow-Up Model for Type 1 Diabetes in Children Leads to Higher Glycemic Control
Julia Vonasek1, Isabelle M Larsen2,3, Amar Nikontovic4
1Pediatric Department, North Denmark Regional Hospital, Hjørring, Denmark.
Insights
A new follow-up model significantly improved glycemic control in children with type 1 diabetes (T1D). The model increased well-regulated diabetes cases and lowered mean HbA1c levels, reducing complication risks.
Area of Science:
- Pediatrics
- Endocrinology
- Metabolic Disorders
Background:
- Poor glycemic control in children with type 1 diabetes (T1D) increases the risk of long-term diabetic complications.
- In 2016, only one-third of pediatric T1D patients at North Denmark Regional Hospital achieved well-regulated blood glucose levels (HbA1c ≤ 58 mmol/mol).
Purpose of the Study:
- To evaluate the effectiveness of a novel, standardized follow-up model for improving glycemic control in pediatric T1D patients.
- To assess the impact of the model on mean HbA1c levels in children with poorly regulated diabetes.
Main Methods:
- A cohort of children aged 0-18 with T1D was studied.
- A standardized follow-up protocol was implemented for patients with HbA1c > 58 mmol/mol, involving closer monitoring until glycemic control improved.
Main Results:
- Following model implementation, the proportion of well-regulated T1D patients increased from one-third to two-thirds.
- Poorly regulated diabetes (HbA1c > 75 mmol/mol) decreased from 19% to a few percent.
- Mean HbA1c levels decreased by approximately 10 mmol/mol (0.8%) after the model's full implementation.
Conclusions:
- The standardized follow-up model effectively increased the rate of well-regulated diabetes in pediatric T1D patients.
- The intervention led to a significant reduction in mean HbA1c, indicating improved overall glycemic control.
Abstract:
Background: Poor glycemic control in type 1 diabetes (T1D) in children leads to a higher risk of diabetic complications. In the pediatric department at the North Denmark Regional Hospital, only one-third of all children with diabetes were well-regulated, defined as HbA1c no more than 58 mmol/mol (7.5%), in 2016. Therefore, a novel follow-up model was developed to increase the proportion of children with well-regulated T1Ds. The aim of this study was to evaluate the effect of a standardized follow-up model for poorly regulated diabetes on mean HbA1c. Methods: All children aged 0-18 with T1Ds were included in this study. A novel standardized follow-up model was developed if HbA1c was greater than 58 mmol/mol (7.5%), in which children were followed more closely until improvement in glycemic control. Results: In the reference year, only one-third of children with diabetes were well-regulated and 19% were poorly regulated (HbA1c greater than 75 mmol/mol (9.0%)). After fully implementing the model, two-thirds of the children had well-regulated diabetes, and only a few percent had poorly regulated diabetes. The mean HbA1c decreased by almost 10 mmol/mol (or 0.8%) from the reference year to the following years when the model was fully implemented. Conclusion: This follow-up model for poorly regulated diabetes increased the fraction of children with well-regulated diabetes in our clinic and significantly decreased mean HbA1c.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes: Symptoms, Diagnosis, and Complications

